| abstract |
Disclosed are complexes of a compound of Formula 1, a stereoisomer thereof, or a tautomer of a compound of Formula 1, or a stereoisomer thereof, and a cyclodextrin, wherein the complex is an amorphous solid. The present disclosure also relates to materials and methods for preparing the complexes, pharmaceutical compositions comprising the complexes, and the complexes for the treatment of Type I hypersensitivity reactions, autoimmune diseases, inflammatory disorders, cancer, non-malignant proliferative disorders , and other conditions associated with BTK. |